ACORN BIOVENTURES, L.P. purchased 1.40M shares of ONKURE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $2.59M. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/19/2025ACC: 0000950170-25-074459
10% Owner
Since Oct 2024
+1.40M
Net shares
Net buyer
$2.59M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1.40M acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+270.27K
Price / share
$1.85
Trade value
$500K
% of position
18.8%
5/15/2025
1.44M→1.71M
Common Stock
Indirect
Shares
+1.13M
Price / share
$1.85
Trade value
$2.09M
% of position
New position
5/15/2025
0.00→1.13M
Total
Net shares
+1.40M
Net value
$2.59M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2025 | P · Purchase | +270.27K | $1.85 | $500K | 18.8% | 1.44M | 1.71M |
| Common Stock Indirect | 5/15/2025 | P · Purchase | +1.13M | $1.85 | $2.09M | New position | 0.00 | 1.13M |
| Total | +1.40M | $2.59M | ||||||
Derivative Transactions0
No derivative transactions reported